Science Explorer Back to mapMap
Discussion
Company · Rotterdam · Netherlands

Pharmerit (Netherlands)

pharmerit.comROR OpenAlex
Research works
113
▼ 91% vs 2018-21
Citations
1.2k
10.5 per fractional work
Top-10% rate
12.8%
all institutions 10.0%
Open access
36%
world 40%
International
62%
world 18%
Pharmerit (Netherlands)

Not ranked overall: Pharmerit (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Pharmerit (Netherlands) work in?

In all years, 59% of research at Pharmerit (Netherlands) is in Health Sciences, 31% in Social Sciences. Its largest fields are Medicine (57%), Economics, Econometrics and Finance (24%), Biochemistry, Genetics and Molecular Biology (4%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 67 fractional works · 59.0% of its workMedicine: 64 fractional works · 56.5% of its workPulmonary and Respiratory Medicine: 9 fractional works · 7.7% of its workOncology: 5 fractional works · 4.3% of its workEndocrinology, Diabetes and Metabolism: 5 fractional works · 4.0% of its workHematology: 4 fractional works · 3.7% of its workSurgery: 4 fractional works · 3.3% of its workCardiology and Cardiovascular Medicine: 3 fractional works · 3.0% of its workInfectious Diseases: 3 fractional works · 3.0% of its workPhysiology: 3 fractional works · 2.9% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 2.5% of its workEpidemiology: 3 fractional works · 2.3% of its workPsychiatry and Mental health: 2 fractional works · 2.2% of its workGenetics: 2 fractional works · 2.1% of its workHepatology: 2 fractional works · 2.0% of its workImmunology and Allergy: 2 fractional works · 2.0% of its workRheumatology: 2 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 1.4% of its workPathology and Forensic Medicine: 1 fractional works · 1.1% of its workOphthalmology: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 0.9% of its workFamily Practice: 1 fractional works · 0.6% of its workInternal Medicine: 1 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.9% of its workHealth Professions: 3 fractional works · 2.4% of its workGeneral Health Professions: 2 fractional works · 1.8% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workSocial Sciences: 35 fractional works · 30.9% of its workEconomics, Econometrics and Finance: 27 fractional works · 24.2% of its workEconomics and Econometrics: 27 fractional works · 24.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 3 fractional works · 2.6% of its workStatistics, Probability and Uncertainty: 2 fractional works · 1.6% of its workManagement Science and Operations Research: 1 fractional works · 1.0% of its workSocial Sciences: 2 fractional works · 1.6% of its workDemography: 1 fractional works · 0.7% of its workSociology and Political Science: 1 fractional works · 0.6% of its workHealth: 0 fractional works · 0.3% of its workPsychology: 2 fractional works · 1.4% of its workClinical Psychology: 1 fractional works · 1.0% of its workApplied Psychology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 0.7% of its workPhilosophy: 1 fractional works · 0.7% of its workBusiness, Management and Accounting: 0 fractional works · 0.4% of its workManagement of Technology and Innovation: 0 fractional works · 0.4% of its workLife Sciences: 8 fractional works · 7.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 3.8% of its workMolecular Biology: 2 fractional works · 1.9% of its workCancer Research: 1 fractional works · 0.9% of its workGenetics: 1 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 1.7% of its workImmunology: 1 fractional works · 0.9% of its workVirology: 0 fractional works · 0.4% of its workMicrobiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 1.4% of its workPharmacology: 1 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 3 fractional works · 2.8% of its workMathematics: 1 fractional works · 1.0% of its workStatistics and Probability: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.9% of its workEnergy: 0 fractional works · 0.4% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.3% of its workComputer Graphics and Computer-Aided Design: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 0 fractional works · 0.1% of its workALL ITS WORKPharmerit(Netherlands)113fractional works, all years
Life Sciences7%Physical Sciences3%Health Sciences59%Social Sciences31%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine6456.5%
    2. Health Professions32.4%
    3. Nursing00.1%
    1. Economics, Econometrics and Finance2724.2%
    2. Decision Sciences32.6%
    3. Social Sciences21.6%
    4. Psychology21.4%
    5. Arts and Humanities10.7%
    6. Business, Management and Accounting00.4%
    1. Biochemistry, Genetics and Molecular Biology43.8%
    2. Immunology and Microbiology21.7%
    3. Pharmacology, Toxicology and Pharmaceutics21.4%
    4. Neuroscience00.2%
    5. Agricultural and Biological Sciences00.1%
    1. Mathematics11.0%
    2. Environmental Science10.9%
    3. Energy00.4%
    4. Computer Science00.3%
    5. Engineering00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Pharmerit (Netherlands)?

Ranked on the quality score, Walter Bouwmeester, Krystallia Pantiri and Sonja Kroep lead among researchers whose main affiliation is Pharmerit (Netherlands).

  1. 1 Walter Bouwmeester Netherlands · #1,516,727 worldwide 3.6k citations · 35 works
  2. 2 Krystallia Pantiri Netherlands · #1,673,441 worldwide 735 citations · 19 works
  3. 3 Sonja Kroep Netherlands · #1,928,593 worldwide 919 citations · 75 works
  4. 4 Marieke Heisen Netherlands · #2,099,991 worldwide 595 citations · 25 works
  5. 5 Natalie S. Houwing Netherlands · #2,386,606 worldwide 747 citations · 15 works
  6. 6 Craig Bennison Netherlands · #2,404,149 worldwide 640 citations · 40 works
  7. 7 Mata Charokopou Netherlands · #2,938,941 worldwide 611 citations · 52 works
  8. 8 M. Hensen Netherlands · #3,268,126 worldwide 92 citations · 18 works
  9. 9 BA Van Hout Netherlands · #3,821,107 worldwide 91 citations · 48 works
  10. 10 Olaf Schoeman Netherlands · #4,050,016 worldwide 202 citations · 22 works
All ranked researchers at Pharmerit (Netherlands)

What are the most cited papers from Pharmerit (Netherlands)?

The most cited paper from Pharmerit (Netherlands) is "Surgical vs Nonsurgical Treatment of Adults With Displaced Fractures of the Proximal Humerus" (Amar Rangan, Helen HG Handoll, Stephen Brealey et al., 2015), with 553 citations. Next come "A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)" (407) and "Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature" (234).

Most cited papers
#PaperReleasedCitations
1 Surgical vs Nonsurgical Treatment of Adults With Displaced Fractures of the Proximal Humerus Amar Rangan, Helen HG Handoll, Stephen Brealey et al. · JAMA 10 Mar 2015 553
2 A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020) Michael Urbich, Gary A. Globe, Krystallia Pantiri et al. · PharmacoEconomics ReviewOpen access 19 Aug 2020 407
3 Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature Cathelijne Alleman, Kirsten Y Westerhout, Marja Hensen et al. · Diabetes Research and Clinical Practice Open access 5 May 2015 234
4 A simulation study of sample size demonstrated the importance of the number of events per variable to develop prediction models in clustered data Laure Wynants, Walter Bouwmeester, Karel G.M. Moons et al. · Journal of Clinical Epidemiology Open access 13 Feb 2015 175
5 The ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial – a pragmatic multicentre randomised controlled trial evaluating the clinical effectiveness and cost-effectiveness of surgical compared with non-surgical treatment for proximal fracture of the humerus in adults Helen HG Handoll, Stephen Brealey, Amar Rangan et al. · Health Technology Assessment Open access Mar 2015 147
All 62 most cited papers, with filters and sorting

Which keywords describe research at Pharmerit (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Prognostic Factors, Pharmaceutical Industry, Clinical Trials, Treatment and Drug Development Costs.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life18▲ 12×13 topics
  2. Cost-effectiveness Analysis14▲ 158×1 topic
  3. Health Utility Measures14▲ 158×1 topic
  4. Epidemiology11▲ 2.3×34 topics
  5. Treatment8▲ 5.2×12 topics
  6. Prognostic Factors7▲ 14×7 topics
  7. Pharmaceutical Industry7▲ 156×2 topics
  8. Clinical Trials7▲ 9.8×6 topics
  9. Drug Development Costs6▲ 207×1 topic
  10. Generic Drugs6▲ 207×1 topic
  11. Clinical Guidelines6▲ 16×6 topics
  12. Immunotherapy5▲ 7.0×6 topics
  13. Cost of Care4▲ 197×1 topic
  14. Financial Toxicity4▲ 197×1 topic
  15. Genetic Mutations4▲ 6.2×4 topics
  16. Glycemic Control4▲ 23×3 topics
  17. Insulin Therapy4▲ 29×3 topics
  18. Immune Response3▲ 4.9×7 topics
  19. Medication Adherence3▲ 52×2 topics
  20. Antiretroviral Therapy3▲ 13×4 topics
  21. Diabetes3▲ 5.6×6 topics
  22. Molecular Characterization3▲ 15×3 topics
  23. Adverse Drug Reactions3▲ 41×2 topics
  24. Publication Bias3▲ 48×2 topics
  25. Asthma3▲ 19×2 topics
  26. Metastatic3▲ 39×1 topic
  27. Renal Cell Carcinoma3▲ 75×1 topic
  28. Guidelines3▲ 5.0×8 topics
  29. Off-Label Drug Use3▲ 63×1 topic
  30. Pediatric Pharmacokinetics3▲ 63×1 topic
  31. Rituximab3▲ 15×2 topics
  32. Type 2 Diabetes3▲ 12×3 topics
  33. Minimal Residual Disease2▲ 31×2 topics
  34. Antiviral Therapy2▲ 13×2 topics
  35. Cardiovascular Outcomes2▲ 46×1 topic
  36. Glucose Control2▲ 46×1 topic
  37. HIV Infection2▲ 16×2 topics
  38. Liver Disease2▲ 14×2 topics
  39. Hepatitis C Virus2▲ 34×1 topic
  40. Ribavirin2▲ 34×1 topic

Which research topics does Pharmerit (Netherlands) publish most on?

By volume in 2022-now: Esophageal Cancer Research and Treatment, Economic and Financial Impacts of Cancer, Breast Cancer Treatment Studies and Lung Cancer Treatments and Mutations.

Esophageal Cancer Resear…1Esophageal Cancer Research and Treatment: 1 fractional worksEconomic and Financial Impacts of Cancer: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksHealth Systems, Economic…0Health Systems, Economic Evaluations, Quality of Life: 0 fractional worksHeterotopic Ossification and Related Conditions: 0 fractional worksCystic Fibrosis Research Advances: 0 fractional worksInhalation and Respiratory Drug Delivery: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksChildhood Cancer Survivors' Quality of Life: 0 fractional works
SurgeryEconomics and EconometricsCancer ResearchPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Esophageal Cancer Research and Treatment Surgery 1 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  3. 3 Breast Cancer Treatment Studies Cancer Research 0 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  6. 6 Heterotopic Ossification and Related Conditions Rheumatology 0 works
  7. 7 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 0 works
  8. 8 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  10. 10 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.2%not open63.8%

World: 40% of research is openly available.

with international co-authors61.6%domestic only38.4%

World: 18% is written across borders.

How has Pharmerit (Netherlands)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Pharmerit (Netherlands) as a percentage of every work published that year, 0.0000031% in 2024.

still counting0.00020%0.00040%0.00060%Pharmerit (Netherlands)0.0000090% in 2025200020102020

Fractional works of Pharmerit (Netherlands) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rotterdam

All research institutions in Rotterdam

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Pharmerit (Netherlands). Posts are plain text and can be reported.